Synthesis and characterisation of a boron-rich symmetric triazine bearing a hypoxia-targeting nitroimidazole moiety

Keyphrases

• Tumor Tissue 100%
• Triazine 100%
• Nitroimidazole 100%
• Boron-rich 100%
• 2-nitroimidazole 100%
• Hypoxia Targeting 100%
• Boron Compounds 100%
• Cancer Treatment 50%
• Hypoxia 50%
• Myeloma Cells 50%
• High Ratio 50%
• Normal Human 50%
• Boron 50%
• Carborane 50%
• Anticancer Treatment 50%
• Conventional Treatment 50%
• Boron Neutron Capture Therapy 50%
• Primary Fibroblasts 50%
• Active Part 50%
• Hypoxic Cells 50%
• No Toxicity 50%
• Boron Accumulation 50%
• Bioreduction 50%
• Binary Therapy 50%
• Nitroimidazole Derivatives 50%
• PEG Spacer 50%
• Hypoxic Zone 50%
• Hypoxia Markers 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Hypoxia 100%
• Triazine 100%
• Nitroimidazole 100%
• Neoplasm 66%
• Malignant Neoplasm 33%
• Multiple Myeloma 33%
• Normal Human 33%
• Polyethylene Glycol 33%
• 2 Nitroimidazole Derivative 33%
• Boron Derivative 33%
• 2 Nitroimidazole 33%

Material Science

• Boron 100%
• Tumor 40%
• Polyethylene Glycol 20%
• Boron Compound 20%
• Fibroblast 20%